Inactivation of the CDKN2/pl6/MTS1 Gene Is Frequently Associated with Aberrant DNA Methylation in All Common Human Cancers

Cancer Research

Volumn 55, Issue 20, 1995, Pages 4525-4530

  Herman, James G ^a   Lapidus, Rena G ^a   Issa, Jean Pierre J ^a   Davidson, Nancy E ^a   Sidransky, David ^a,c   Baylin, Stephen B ^a,b   Merlo, Adrian ^c   Mao, Li ^c  

^a The Oncology Center ^*  (United States)

^b Department of Medicine ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMOSOME 9P; COLON CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE DELETION; GENE REPRESSION; GLIOMA; HEAD AND NECK CARCINOMA; HOMOZYGOSITY; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CPG ISLANDS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMAN; METHYLATION; PROMOTER REGIONS (GENETICS); PROTEIN P16; RESTRICTION MAPPING; RNA, NEOPLASM; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028845142     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264:436–440, 1994.
2. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368:753–756, 1994.
3. Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., and Sidransky, D. Rates of pl6 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265:415–417, 1994.
4. Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., Beach, D. H., and Harris, C. C. Mutations and altered expression of pl6INK4 in human cancer. Proc. Natl. Acad. Sci. USA, 91:11045–11049, 1994.
5. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W. C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A. J., and Testa, J. R. pi6 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54:5547–5551, 1994.
6. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M., Singh, A. D., Shields, J. A., Shields, C. L., Croce, C. M., and Huebner, K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res., 54:5269–5272, 1994.
7. Spruck, C. H., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M. F., Gonzales, F., Tsai, Y. C., and Jones, P. A. pl6 gene in uncultured tumours. Nature (Lond.), 370:183–184, 1994.
8. Xu, L., Sgroi, D., Sterner, C. J., Beauchamp, R. L., Pinney, D. M., Keel, S., Ueki, K., Rutter, J. L., Buckler, A. J., Louis, D. N., Louis, D. D., Gusella, J. F., and Ramesh, V. Mutational analysis of CDKN2 (MTSl/pl6ink4) in human breast carcinomas. Cancer Res., 54:5262–5264, 1994.
9. Tate, P. H., and Bird, A. P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev., 3:226–231, 1993.
10. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91:9700–9704, 1994.
11. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5’ CpG island methylation is associated with transcriptional silencing of the tumor suppressor pl6/CDKN2/MTSl in human cancers. Nat. Med., 1:686–692, 1995.
12. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat. Genet., 7:536–540, 1994.
13. Merlo, A., Gabrielson, E., Askin, F., and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54:640–642, 1994.
14. Latif, F., Fivash, M., Glenn, G., Tory, K., Orcutt, M. L., Hampsch, K., Delisio, J., Lerman, M., Cowan, J., Beckett, M., and Weichselbaum, R. Chromosome 3p deletions in head and neck carcinomas:statistical ascertainment of allelic loss. Cancer Res., 52:1451–1456, 1992.
15. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321:209–213, 1986.
16. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gavielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Issacs, W., Schwab, D., and Sidransky, D. High frequency of homozygous deletion at pl6/CDKN2 in primary human tumors. Nat. Genet., in press, 1995.
17. Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D. J., and Rollins, B. J. Reciprocal Rb inactivation and pl6INK4 expression in primary lung cancers and cell lines. Cancer Res., 55:505–509, 1995.
18. T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., and Fung, Y. K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science (Washington DC), 242:263–266, 1988.
19. Gope, R., and Gope, M. L. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol. Cell. Biochem., 110:123–133, 1992.
20. Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P., and Lee, W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247:712–715, 1990.
21. Gingrich, J. R., Tucker, J. A., Walther, P. J., Day, J. W., Poulton, S. H. M., and Webb, K. S. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J. Urol., 246:915–919, 1991.
22. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investigative Urology, 17:16–23, 1979.
23. Iizumi, T., Yazaki, T., Kanoh, S., Rondo, I., and Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-PR1). J. Urol., 137:1304–1306, 1987.
24. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 21:274–281, 1978.
25. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43:1809–1818, 1983.
26. D'Amico, D., Carbone, D., Mitsudomi, T., Nau, T., Fedorko, J., Russell, E., Johnson, B., Buchhagen, D., Bodner, S., Phelps, R., Gazdar, A. F., and Minna, J. D. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene, 7:339–346, 1992.
27. Walker, D. G., Duan, W., Popovic, E. A., Kaye, A. H., Tomlinson, F. H., and Lavin, M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res., 55:20–23, 1995.
28. Okamoto, A., Hussain, S. P., Hagiwara, K., Spillare, E. A., Rusin, M. R., Demetrick, D. J., Serrano, M., Hannon, G. J., Shiseki, M., Zariwala, M., Xiong, Y., Beach, D. H., Yokota, J., and Harris, C. C. Mutations in the pl6MK4/MTSl/CDKN2y p!5MK4B/MTS2, and pl8 genes in primary and metastatic lung cancer. Cancer Res., 55:1448–1451, 1995.
29. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the pl6 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8:27–32, 1994.
30. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline pl6 mutations in familial melanoma. Nat. Genet., 8:15–21, 1994.
31. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A., Methylation fo the 5’ CpG island of the pl6/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55:4531–4535, 1995.